CTRA vs LBRX · P/E 15, rev $7.64B vs $803.4M cap
Coterra Energy Inc (CTRA) versus LB Pharmaceuticals Inc Common Stock (LBRX) — a side-by-side from cached financials, not a winner call.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Latest reported CTRA revenue for 2025-12-31 was $7.64B. Net income was $1.72B. Revenue was up 40.1% from 2024-12-31 to 2025-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
LBRX does not have a complete income-statement cache yet.
CTRA currently screens at market cap $20.46B and trailing P/E 15.2. LBRX currently screens at market cap $803.4M.
Not investment advice. Open the CTRA and LBRX stock pages for the full models.
Not investment advice.